Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sumitomo Chemical among 4 stocks that closed crossing below VWAP
Four Nifty500 stocks, Zydus Wellness, Sumitomo Chemical India, Max Healthcare Institute, and Zensar Technologies, closed over 1.5% below their VWAP on July 6, indicating potential bearish momentum and increased selling pressure, according to technical scan data.
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
Zydus Lifesciences share price jumps over 6% after Q4 results. Should you buy or sell?
Zydus Lifesciences shares rose over 6% after strong Q4FY26 earnings, reporting a 14.6% increase in net profit to ₹1,592.9 crore. Revenue grew to ₹7,587 crore, driven by the consumer wellness segment. The board approved a ₹1,100 crore share buyback and a Re 1 dividend.